Supplement F: Laboratory Guidance
Public Health Guidance for Community-Level Preparedness and Response to Severe Acute Respiratory Syndrome (SARS) Version 2/3*
Contents of this Section
Footnote *
This version of Supplement F includes additional guidance on the types of specimens to collect for SARS-CoV testing and the optimal timing for collection. Three new appendices have been included:
- Appendix F3: Guidelines for Clinicians: The Consent Process for SARS-CoV RT-PCR and EIA Testing at CDC and Public Health Laboratories
- Appendix F6: Guidelines for Medical Surveillance of Laboratory Personnel Working with SARS-CoV
- Appendix F8: Guidelines for Laboratory Diagnosis of SARS-CoV Infection
Related Pages
- Laboratory Testing and Specimens
- Laboratory was Source of SARS-CoV Infection in Singapore Patient
- Sup I - Infection Control for Laboratory and Pathology Procedures, Supplement I of Public Health Guidance for Community-Level Preparedness and Response to Severe Acute Respiratory Syndrome (SARS)
- Laboratory Biosafety
- Informed Consent for Laboratory Testing
- Laboratory Testing and Diagnosis
Images and logos on this website which are trademarked/copyrighted or used with permission of the trademark/copyright or logo holder are not in the public domain. These images and logos have been licensed for or used with permission in the materials provided on this website. The materials in the form presented on this website may be used without seeking further permission. Any other use of trademarked/copyrighted images or logos requires permission from the trademark/copyright holder...more
This graphic notice means that you are leaving an HHS Web site. For more information, please see the Exit Notification and Disclaimer policy.
Contact Us:
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348
8am-8pm ET/Monday-Friday
Closed Holidays - cdcinfo@cdc.gov